Market Trends of MEA Bladder Cancer Therapeutics & Diagnostics Industry
This section covers the major market trends shaping the MEA Bladder Cancer Therapeutics & Diagnostics Market according to our research experts:
Radiation Therapy is Expected to Cover a Large Share of the Market
Bladder cancer is highly prevalent diseases and it increases with age. As per a 2018 Globocan report, the bladder cancer incidence in the Middle East and Africa region is expected to increase in the future. The most advanced modalities of bladder cancer therapeutics include immunotherapy but, the most widely used modality in bladder cancer is radiation therapy. This is due to historical use-prevalence of radiation therapies in various forms of cancers and also because chemotherapy is associated with low specificity and side-effects. Radiation therapy also, offers best in class efficacy, in terms of dose frequency and pricing, when compared to other therapeutic modalities in bladder cancer management. Advancements in radiation therapy and expected increase in number of bladder cancer patients is expected to help the growth of this market.
